Author Interviews, Mayo Clinic, Weight Research / 27.09.2017
Blocking Gherlin May Be Key To Preventing Weight Gain After Dieting
MedicalResearch.com Interview with:
Dr. W. Stephen Brimijoin PhD
Department of Molecular Pharmacology and Experimental Therapeutics
Mayo Clinic, Rochester, MN 55905
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: The background for this study was:
1) Ordinary C57 black mice readily become obese when given unrestricted access to high-fat mouse chow.
2) If the obese mice are put on a forced calorie restricted diet they will regain their previous normal healthy weight. However, if they are given unrestricted access to their previous “normal” low-fat mouse chow, they will rebound into obesity. This effect can be seen as a model of human obesity and the difficulties that formerly obese men and women face in maintaining healthy body mass gained after dieting.
3) The literature on obesity provided reason to believe that this self-defeating behavioral cycle involves ghrelin, the so-called “hunger hormone.”
4) We had recently shown that the plasma enzyme called “butyrylcholinesterase” was a key regulator of active ghrelin. Therefore, it seemed plausible that raising enzyme levels would reduce ghrelin and, in turn, would blunt food craving.
(more…)